Table 1.
Details of studies included in the meta-analysis
| Reference | Year | Ethnicity/Country | CMV detection | N | Male (%) | Cases (n = 2347) | Controls (n = 7310) | Result | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CMV+ | CMV- | CMV+ | CMV- | |||||||
| [12] | 2014 | Han/China | ELISA, PCR | 800 | 42.8 | 433 | 49 | 288 | 30 | CMV antibody titers associated with blood pressure and hypertension |
| Kazakh/China | 800 | 42.0 | 452 | 15 | 311 | 22 | CMV seropositivity associated with hypertension in males | |||
| [16] | 2013 | Iran | ELISA | 1754 | 49.2 | 442 | 17 | 1193 | 102 | Pathogen burden not associated with hypertension |
| [13] | 2012 | USA | ELISA | 6303 | 47.3 | 534 | 405 | 2902 | 2462 | CMV seropositivity associated with hypertension in women |
ELSA enzyme-linked immunosorbent assay, PCR polymerase chain reaction, CMV cytomegalovirus